Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 11, pp 3428–3435 | Cite as

Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients

  • Timothy E. Newhook
  • Whitney L. Dewhurst
  • Timothy J. Vreeland
  • Xuemei Wang
  • Jose Soliz
  • B. Bryce Speer
  • Shannon Hancher-Hodges
  • Chun Feng
  • Morgan L. Bruno
  • Michael P. Kim
  • Thomas A. Aloia
  • Jean-Nicolas Vauthey
  • Jeffrey E. Lee
  • Matthew H. G. Katz
  • Ching-Wei D. TzengEmail author
Health Services Research and Global Oncology
  • 109 Downloads

Abstract

Background

Despite advances in enhanced surgical recovery programs, strategies limiting postoperative inpatient opioid exposure have not been optimized for pancreatic surgery. The primary aims of this study were to analyze the magnitude and variations in post-pancreatectomy opioid administration and to characterize predictors of low and high inpatient use.

Methods

Clinical characteristics and inpatient oral morphine equivalents (OMEs) were downloaded from electronic records for consecutive pancreatectomy patients at a high-volume institution between March 2016 and August 2017. Regression analyses identified predictors of total OMEs as well as highest and lowest quartiles.

Results

Pancreatectomy was performed for 158 patients (73% pancreaticoduodenectomy). Transversus abdominus plane (TAP) block was performed for 80% (n = 127) of these patients, almost always paired with intravenous patient-controlled analgesia (IV-PCA), whereas 15% received epidural alone. All the patients received scheduled non-opioid analgesics (median, 2). The median total OME administered was 423 mg (range 0–4362 mg). Higher total OME was associated with preoperative opioid prescriptions (p < 0.001), longer hospital length of stay (LOS; p < 0.001), and no epidural (p = 0.006). The lowest and best quartile cutoff was 180 mg of OME or less, whereas the highest and worst quartile cutoff began at 892.5 mg. After adjustment for inpatient team, only epidural use [odds ratio (OR) 0.3; p = 0.04] predicted lowest-quartile OME. Preoperative opioid prescriptions (OR 8.1; p < 0.001), longer operative time (OR 3.4; p = 0.05), and longer LOS (OR 1.1; p = 0.007) predicted highest-quartile OME.

Conclusions

Preoperative opioid prescriptions and longer LOS were associated with increased inpatient OME, whereas epidural use reduced inpatient OME. Understanding the predictors of inpatient opioid use and the variables predicting the lowest and highest quartiles can inform decision-making regarding preoperative counseling, regional anesthetic block choice, and novel inpatient opioid weaning strategies to reduce initial postoperative opioid exposure.

Notes

References

  1. 1.
    Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. NCHS Data Brief. 2014(166):1–8.Google Scholar
  2. 2.
    Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg. 2017;152:1066–71.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Feinberg AE, Chesney TR, Srikandarajah S, Acuna SA, McLeod RS, Best Practice in Surgery G. Opioid use after discharge in postoperative patients: a systematic review. Ann Surg. 2018;267:1056–62.Google Scholar
  4. 4.
    Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk factors for prolonged opioid use after major surgery: population-based cohort study. BMJ. 2014;348:g1251.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Soneji N, Clarke HA, Ko DT, Wijeysundera DN. Risks of developing persistent opioid use after major surgery. JAMA Surg. 2016;151:1083–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Brummett CM, Waljee JF, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152:e170504.Google Scholar
  8. 8.
    Lee JS, Hu HM, Edelman AL, et al. New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol. 2017;35:4042–9.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Tuminello S, Schwartz RM, Liu B, et al. Opioid use after open resection or video-assisted thoracoscopic surgery for early-stage lung cancer. JAMA Oncol. 2018.Google Scholar
  10. 10.
    Chen EY, Marcantonio A, Tornetta P III. Correlation between 24-hour predischarge opioid use and amount of opioids prescribed at hospital discharge. JAMA Surg. 2018;153:e174859.CrossRefPubMedGoogle Scholar
  11. 11.
    Stafford C, Francone T, Roberts PL, Ricciardi R. What factors are associated with increased risk for prolonged postoperative opioid usage after colorectal surgery? Surg Endosc. 2018;32:3557–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Hwang RF, Wang H, Lara A, et al. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol. 2008;15:1356–66.CrossRefGoogle Scholar
  13. 13.
    Denbo JW, Bruno M, Dewhurst W, et al. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery. 2018;164:424–31.CrossRefPubMedGoogle Scholar
  14. 14.
    Schwarz L, Bruno M, Parker NH, et al. Active surveillance for adverse events within 90 days: the standard for reporting surgical outcomes after pancreatectomy. Ann Surg Oncol. 2015;22:3522–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Denbo JW, Slack RS, Bruno M, et al. Selective perioperative administration of pasireotide is more cost-effective than routine administration for pancreatic fistula prophylaxis. J Gastrointest Surg. 2017;21:636–46.CrossRefPubMedGoogle Scholar
  16. 16.
    Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250:177–86.CrossRefPubMedGoogle Scholar
  17. 17.
    Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161:584–91.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Newhook TE, Vreeland TJ, Dewhurst WL, et al. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Ann Surg. 2018. November 29 epub ahead of print.Google Scholar
  20. 20.
    George MJ. The site of action of epidurally administered opioids and its relevance to postoperative pain management. Anaesthesia. 2006;61:659–64.CrossRefPubMedGoogle Scholar
  21. 21.
    Kane S. Opioid (opiate) equianagesia conversion calculator. Retrieved 10 June 2018 at ClinCalc: http://clincalc.com/opioids.
  22. 22.
    American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th ed. American Pain Society, Glenview, IL, 2008.Google Scholar
  23. 23.
    Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001;22:672–87.CrossRefPubMedGoogle Scholar
  24. 24.
    Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Symptom Manage. 2001;21:397–406.CrossRefPubMedGoogle Scholar
  25. 25.
    Patanwala AE, Duby J, Waters D, Erstad BL. Opioid conversions in acute care. Ann Pharmacother. 2007;41:255–66.CrossRefPubMedGoogle Scholar
  26. 26.
    Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use–United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66:265–9.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Holte K, Kehlet H. Effect of postoperative epidural analgesia on surgical outcome. Minerva Anestesiol. 2002;68:157–61.PubMedGoogle Scholar
  28. 28.
    Kehlet H, Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anaesth. 2001;87:62–72.CrossRefPubMedGoogle Scholar
  29. 29.
    Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110:107–14.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Kim BJ, Aloia TA. What Is “enhanced recovery” and how can i do it? J Gastrointest Surg. 2018;22:164–71.CrossRefPubMedGoogle Scholar
  31. 31.
    Shah DR, Brown E, Russo JE, et al. Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg. 2013;17:660–7.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Marret E, Remy C, Bonnet F. Postoperative Pain Forum G: meta-analysis of epidural analgesia versus parenteral opioid analgesia after colorectal surgery. Br J Surg. 2007;94:665–73.CrossRefPubMedGoogle Scholar
  33. 33.
    Bartha E, Carlsson P, Kalman S. Evaluation of costs and effects of epidural analgesia and patient-controlled intravenous analgesia after major abdominal surgery. Br J Anaesth. 2006;96:111–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Konigsrainer I, Bredanger S, Drewel-Frohnmeyer R, et al. Audit of motor weakness and premature catheter dislodgement after epidural analgesia in major abdominal surgery. Anaesthesia 2009;64:27–31.CrossRefPubMedGoogle Scholar
  35. 35.
    Sugimoto M, Nesbit L, Barton JG, Traverso LW. Epidural anesthesia dysfunction is associated with postoperative complications after pancreatectomy. J Hepatobiliary Pancreat Sci. 2016;23:102–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Axelrod TM, Mendez BM, Abood GJ, Sinacore JM, Aranha GV, Shoup M. Perioperative epidural may not be the preferred form of analgesia in select patients undergoing pancreaticoduodenectomy. J Surg Oncol. 2015;111:306–10.CrossRefPubMedGoogle Scholar
  37. 37.
    Aloia TA, Kim BJ, Segraves-Chun YS, et al. A randomized controlled trial of postoperative thoracic epidural analgesia versus intravenous patient-controlled analgesia after major hepatopancreatobiliary surgery. Ann Surg. 2017;266:545–54.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Ladha KS, Gagne JJ, Patorno E, et al. Opioid overdose after surgical discharge. JAMA. 2018;320:502–4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Repeat quadratus lumborum block to reduce opioid need in patients after pancreatic surgery. Retrieved 21 December 2018 at https://ClinicalTrials.gov/show/NCT03745794.

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Timothy E. Newhook
    • 1
  • Whitney L. Dewhurst
    • 1
  • Timothy J. Vreeland
    • 1
  • Xuemei Wang
    • 2
  • Jose Soliz
    • 3
  • B. Bryce Speer
    • 3
  • Shannon Hancher-Hodges
    • 3
  • Chun Feng
    • 4
  • Morgan L. Bruno
    • 1
  • Michael P. Kim
    • 1
  • Thomas A. Aloia
    • 1
  • Jean-Nicolas Vauthey
    • 1
  • Jeffrey E. Lee
    • 1
  • Matthew H. G. Katz
    • 1
  • Ching-Wei D. Tzeng
    • 1
    Email author
  1. 1.Department of Surgical OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of BiostatisticsThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  3. 3.Department of Anesthesiology and Perioperative MedicineThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  4. 4.Department of Medication Management and AnalyticsThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations